11-134157033-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015261.3(NCAPD3):āc.4237A>Gā(p.Ile1413Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015261.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD3 | NM_015261.3 | c.4237A>G | p.Ile1413Val | missense_variant | 32/35 | ENST00000534548.7 | NP_056076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD3 | ENST00000534548.7 | c.4237A>G | p.Ile1413Val | missense_variant | 32/35 | 1 | NM_015261.3 | ENSP00000433681 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251178Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135748
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461288Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 726980
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74230
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The c.4237A>G (p.I1413V) alteration is located in exon 32 (coding exon 32) of the NCAPD3 gene. This alteration results from a A to G substitution at nucleotide position 4237, causing the isoleucine (I) at amino acid position 1413 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at